Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.

Autoimmune diseases COVAD Digital health Quality of life Sociodemographic factors Survey

Journal

Rheumatology international

ISSN: 1437-160X

Titre abrégé: Rheumatol Int

Pays: Germany

ID NLM: 8206885

Informations de publication

Date de publication:
12 Apr 2024

Historique:

received: 13 11 2023

accepted: 21 02 2024

medline: 13 4 2024

pubmed: 13 4 2024

entrez: 12 4 2024

Statut: aheadofprint

Résumé

The growing recognition of holistic patient care highlights the various factors shaping the quality of life of individuals with autoimmune and rheumatic diseases (AIRDs). Beyond the traditional disease measures, there is an emerging acknowledgment of the less-explored aspects, including subjective well-being, social determinants of health, comorbidities, mental health, and medication adherence. Moreover, digital health services have empowered patients to engage actively in decision-making alongside clinicians. To explore these domains within the context of AIRDs, the "Collating the Voice of People with Autoimmune Diseases" COVAD survey was conceived, a successor of the previous two COVAD surveys. In this document, we present the study protocol in comprehensive detail. The COVAD-3 survey is a cross-sectional patient self-reported e-survey incorporating multiple widely accepted scales/scores to assess various aspects of patients' lifestyles objectively. To ensure the survey's accuracy and usability across diverse regions, it will be translated into multiple languages and subjected to rigorous vetting and pilot testing. It will be distributed by collaborators via online platforms and data will be collected from patients with AIRDs, and healthy individuals over eight months. Data analysis will focus on outcome measures related to various social, demographic, economic, and psychological factors. With the increasing awareness to adopt a holistic treatment approach encompassing all avenues of life, the COVAD-3 survey aims to gain valuable insights into the impact of social, demographic, economic, and psychological determinants of health on the subjective well-being in patients with AIRDs, which will contribute to a better understanding of their overall health and well-being.

Identifiants

DOI: 10.1007/s00296-024-05562-z PMID: 38609655

pubmed: 38609655

doi: 10.1007/s00296-024-05562-z

pii: 10.1007/s00296-024-05562-z

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Wade DT, Halligan PW (2017) The biopsychosocial model of illness: A model whose time has come. Clin Rehabil 31:995–1004

doi: 10.1177/0269215517709890 pubmed: 28730890

Shinjo SK, Kim M, Hoff LS (2023) Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study. Int J Rheum Dis 26:727–739. https://doi.org/10.1111/1756-185X.14636

doi: 10.1111/1756-185X.14636 pubmed: 36872076

Nikiphorou E, Alpizar-Rodriguez D, Gastelum-Strozzi A, Buch A, Peláez-Ballestas I (2021) Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era. Rheumatology (Oxford) 60:2040–2045. https://doi.org/10.1093/RHEUMATOLOGY/KEAA840

doi: 10.1093/RHEUMATOLOGY/KEAA840 pubmed: 33496334

WHO (2022) Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition . Accessed July 10, 2023

Alghamdi SA, Alfares MA, Alsulami RA (2022) Post-COVID-19 Syndrome: Incidence, Risk Factor, and the Most Common Persisting Symptoms. Cureus. https://doi.org/10.7759/CUREUS.32058

doi: 10.7759/CUREUS.32058 pubmed: 36721593 pmcid: 9884402

Armadans-Tremolosa I, Selva-O’Callaghan A, Visauta-Vinacua B, Guilera G, Pinal-Fernández I, Vilardell-Tarrés M (2014) Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol 33:1119–1125. https://doi.org/10.1007/S10067-014-2685-0

doi: 10.1007/S10067-014-2685-0 pubmed: 24894104

Jacobi CE, Mol GD, Boshuizen HC, Rupp I, Dinant HJ, Van Den Bos GA (2003) Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arthritis Rheum 49:567–573. https://doi.org/10.1002/ART.11200

doi: 10.1002/ART.11200 pubmed: 12910565

Kumaradev S, Roux C, Sellam J, Perrot S, Pham T, Dugravot A, Molto A (2022) Socio-demographic determinants in the evolution of pain in inflammatory rheumatic diseases: results from ESPOIR and DESIR cohorts. Rheumatology (Oxford) 61:1496–1509. https://doi.org/10.1093/RHEUMATOLOGY/KEAB562

doi: 10.1093/RHEUMATOLOGY/KEAB562 pubmed: 34270700

van Mierlo T, Fournier R, Ingham M (2015) Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development. PLoS ONE. https://doi.org/10.1371/journal.pone.0129364

doi: 10.1371/journal.pone.0129364 pubmed: 26193653 pmcid: 4508110

De Vera MA, Mailman J, Galo JS (2014) Economics of non-adherence to biologic therapies in rheumatoid arthritis topical collection on health economics and quality of life. Curr Rheumatol Rep 16:1–9. https://doi.org/10.1007/S11926-014-0460-5/TABLES/1

doi: 10.1007/S11926-014-0460-5/TABLES/1

Vangeli E, Bakhshi S, Baker A, Fisher A, Bucknor D, Mrowietz U, Ostor AJ, Peyrin-Biroulet L, Lacerda AP, Weinman J (2015) A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases. Adv Ther 32(11):983–1028. https://doi.org/10.1007/s12325-015-0256-7

doi: 10.1007/s12325-015-0256-7 pubmed: 26547912 pmcid: 4662720

Stoumpos AI, Kitsios F, Talias MA (2023) Digital Transformation in Healthcare: Technology Acceptance and Its Applications. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph20043407

doi: 10.3390/ijerph20043407 pubmed: 36834105 pmcid: 9963556

Stafford IS, Kellermann M, Mossotto E, Beattie RM, MacArthur BD, Ennis S (2020) A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases. NPJ Digit Med 3:30. https://doi.org/10.1038/s41746-020-0229-3

doi: 10.1038/s41746-020-0229-3 pubmed: 32195365 pmcid: 7062883

Health measures (nd) PROMIS https://www.healthmeasures.net/explore-measurement-systems/promis Accessed September 5, 2023

Sen P, Gupta L, Lilleker JB (2022) COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatol Int 42:23–29. https://doi.org/10.1007/S00296-021-05046-4

doi: 10.1007/S00296-021-05046-4 pubmed: 34779868

Sen P, Gupta L, Lilleker JB, Aggarwal V, Kardes S, Milchert M, Gheita T, Salim B, Velikova T, Gracia-Ramos AE, Parodis I, O’Callaghan AS, Nikiphorou E, Tan AL, Cavagna L, Saavedra MA, Shinjo SK, Ziade N, Knitza J, Kuwana M, Cagnotto G, Nune A, Distler O, Chinoy H, Aggarwal V, Aggarwal R (2022) COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatol Int 42(1):23–29. https://doi.org/10.1007/s00296-021-05046-4

doi: 10.1007/s00296-021-05046-4 pubmed: 34779868

(2000) Glossary. Spine 25:3200–3202

Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

pubmed: 7699630

Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, Ramos-Casals M, Dorner T, Bombardieri S, Hachulla E, Brun JG, Kruize AA, Praprotnik S, Tomsic M, Gottenberg JE, Devauchelle V, Devita S, Vollenweider C, Mandl T, Tzioufas A, Carsons S, Saraux A, Sutcliffe N, Vitali C, Bowman SJ (2011) EULAR Sjogren’s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren’s syndrome. Ann Rheum Dis 70(6):968–972. https://doi.org/10.1136/ard.2010.143743

doi: 10.1136/ard.2010.143743 pubmed: 21345815

Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, Maccarone M, Carton L, Otsa K, Sooaar I, Heiberg T, Bertheussen H, Canete JD, Sanchez Lombarte A, Balanescu A, Dinte A, de Vlam K, Smolen JS, Stamm T, Niedermayer D, Bekes G, Veale D, Helliwell P, Parkinson A, Luger T, Kvien TK, Taskforce EP (2014) A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis 73(6):1012–1019

doi: 10.1136/annrheumdis-2014-205207 pubmed: 24790067

The Morisky Medication Adherence Scale: An Overview, (n.d.). https://www.pillsy.com/articles/the-morisky-medication-adherence-scale-definition-alternatives-and-overview (accessed January 1, 2024)

Groll DL, To T, Bombardier C, Wright JG (2005) The development of a comorbidity index with physical function as the outcome. J Clin Epidemiol 58:595–602. https://doi.org/10.1016/j.jclinepi.2004.10.018

doi: 10.1016/j.jclinepi.2004.10.018 pubmed: 15878473

Diener E, Emmons RA, Larsen RJ, Griffin S (1985) The Satisfaction With Life Scale. J Pers Assess 49:71–75. https://doi.org/10.1207/s15327752jpa4901_13

doi: 10.1207/s15327752jpa4901_13 pubmed: 16367493

Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M (2001) Effect of a self-management program on patients with chronic disease. Eff Clin Pract 4(6):256–262

pubmed: 11769298

Ritter PL, Lorig K (2014) The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol 67:1265–1273. https://doi.org/10.1016/j.jclinepi.2014.06.009

doi: 10.1016/j.jclinepi.2014.06.009 pubmed: 25091546

Hughes ME, Waite LJ, Hawkley LC, Cacioppo JT (2004) A Short Scale for Measuring Loneliness in Large Surveys: Results From Two Population-Based Studies. Res Aging 26(6):655–672. https://doi.org/10.1177/0164027504268574

doi: 10.1177/0164027504268574 pubmed: 18504506 pmcid: 2394670

Smilkstein G (1978) The family APGAR: a proposal for a family function test and its use by physicians. J Fam Pract 6(6):1231–1239

pubmed: 660126

Sinval J, Maroco J (2020) Short Index of Job Satisfaction: Validity evidence from Portugal and Brazil. PLoS ONE 15(4):e0231474. https://doi.org/10.1371/journal.pone.0231474

doi: 10.1371/journal.pone.0231474 pubmed: 32287284 pmcid: 7156096

(nd) HINTS. Health Information National Trends Survey. https://hints.cancer.gov/ Accessed September 17, 2023.

Dugan E, Trachtenberg F, Hall MA (2005) Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res 5:64. https://doi.org/10.1186/1472-6963-5-64

doi: 10.1186/1472-6963-5-64 pubmed: 16202125 pmcid: 1262715

Gerymski R (2021) Short sexual well-being scale - A cross-sectional validation among transgender and cisgender people. Heal Psychol Rep 9:276–287. https://doi.org/10.5114/HPR.2021.102349

doi: 10.5114/HPR.2021.102349

Garcia-Conesa MT, Philippou E, Pafilas C, Massaro M, Quarta S, Andrade V, Jorge R, Chervenkov M, Ivanova T, Dimitrova D, Maksimova V, Smilkov K, Ackova DG, Miloseva L, Ruskovska T, Deligiannidou GE, Kontogiorgis CA, Pinto P (2020) Exploring the Validity of the 14-Item Mediterranean Diet Adherence Screener (MEDAS): A Cross-National Study in Seven European Countries around the Mediterranean Region. Nutrients. https://doi.org/10.3390/nu12102960

doi: 10.3390/nu12102960 pubmed: 33339084 pmcid: 7765516

Parodis I, Gomez A, Tsoi A, Chow JW, Pezzella D, Girard C, Stamm TA, Bostrom C (2023) Systematic literature review informing the EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. RMD Open. https://doi.org/10.1136/rmdopen-2023-003297

doi: 10.1136/rmdopen-2023-003297 pubmed: 37532469 pmcid: 10401222

(n d) ICMR Ethical Guidelines. ICMR. https://ethics.ncdirindia.org/icmr_ethical_guidelines.aspx Accessed August 4, 2023

Parodis I, Girard-Guyonvarc’h C, Arnaud L, Distler O, Domjan A, Van den Ende CHM, Fligelstone K, Kocher A, Larosa M, Lau M, Mitropoulos A, Ndosi M, Poole JL, Redmond A, Ritschl V, Alexanderson H, Sjoberg Y, von Perner G, Uhlig T, Varju C, Vriezekolk JE, Welin E, Westhovens R, Stamm TA, Bostrom C (2023) EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis. Ann Rheum Dis. https://doi.org/10.1136/ard-2023-224416

doi: 10.1136/ard-2023-224416 pubmed: 37433575

Emamikia S, Gentline C, Enman Y, Parodis I (2022) How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study. J Clin Med. https://doi.org/10.3390/JCM11071857

doi: 10.3390/JCM11071857 pubmed: 35407466 pmcid: 8999748